These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 7556242)

  • 21. Is There a Carbapenem MIC Cutoff Value That Distinguishes Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem Non-Susceptible Pseudomonas and Acinetobacter Isolates?
    Tamma PD; Wang R; Lewis S; Opene BNA; Simner PJ
    Infect Control Hosp Epidemiol; 2017 Nov; 38(11):1378-1379. PubMed ID: 28965496
    [No Abstract]   [Full Text] [Related]  

  • 22. Outer membrane proteins profiles of Pseudomonas aeruginosa after the post-antibiotic effect of imipenem.
    Hostacká A; Karelová E
    Microbios; 1997; 90(362):45-50. PubMed ID: 9301070
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Carbapenem resistance mechanisms in Pseudomonas aeruginosa: alterations of porin OprD and efflux proteins do not fully explain resistance patterns observed in clinical isolates.
    El Amin N; Giske CG; Jalal S; Keijser B; Kronvall G; Wretlind B
    APMIS; 2005 Mar; 113(3):187-96. PubMed ID: 15799762
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complexity of resistance mechanisms to imipenem in intensive care unit strains of Pseudomonas aeruginosa.
    Fournier D; Richardot C; Müller E; Robert-Nicoud M; Llanes C; Plésiat P; Jeannot K
    J Antimicrob Chemother; 2013 Aug; 68(8):1772-80. PubMed ID: 23587654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antimicrobial susceptibility of Pseudomonas aeruginosa isolated at Kochi Municipal Central Hospital in the last 3 years].
    Nasu Y; Abe M; Ono N; Araki M; Horimi T; Takahashi I
    Jpn J Antibiot; 2004 Oct; 57(5):438-48. PubMed ID: 15655905
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative in vitro killing activity of meropenem versus imipenem against multiresistant nosocomial Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ; Grecka P; Giamarellou H
    J Chemother; 1995 Jun; 7(3):179-83. PubMed ID: 7562010
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transduction of imipenem resistance by wild-type bacteriophages carried by three strains of Pseudomonas aeruginosa isolated from a single source.
    Blahová J; Králiková K; Krcméry V; Mlynarcík D; Trupl J
    J Antimicrob Chemother; 1998 Jun; 41(6):660-2. PubMed ID: 9687107
    [No Abstract]   [Full Text] [Related]  

  • 28. Emergence of Imipenem-Resistant Pseudomonas aeruginosa Clinical Isolates from Egypt Coharboring VIM and IMP Carbapenemases.
    El-Domany RA; Emara M; El-Magd MA; Moustafa WH; Abdeltwab NM
    Microb Drug Resist; 2017 Sep; 23(6):682-686. PubMed ID: 28085553
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutational inactivation of OprD in carbapenem-resistant Pseudomonas aeruginosa isolates from Korean hospitals.
    Kim CH; Kang HY; Kim BR; Jeon H; Lee YC; Lee SH; Lee JC
    J Microbiol; 2016 Jan; 54(1):44-49. PubMed ID: 26727901
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular Characterization of Imipenem-Resistant, Meropenem-Susceptible Pseudomonas aeruginosa with blaVIM₋₂ Phenotype: Potential for Dissemination.
    Pragasam AK; Raghanivedha M; Anandan S; Veeraraghavan B
    Jpn J Infect Dis; 2016; 69(2):159-60. PubMed ID: 26567829
    [No Abstract]   [Full Text] [Related]  

  • 31. Activity of cefepime against resistant strains of Pseudomonas aeruginosa.
    Talon D; Thouverez M; Mulin B
    J Antimicrob Chemother; 1997 Dec; 40(6):909-10. PubMed ID: 9462449
    [No Abstract]   [Full Text] [Related]  

  • 32. Mechanisms responsible for imipenem resistance among Pseudomonas aeruginosa clinical isolates exposed to imipenem concentrations within the mutant selection window.
    Vassilara F; Galani I; Souli M; Papanikolaou K; Giamarellou H; Papadopoulos A
    Diagn Microbiol Infect Dis; 2017 Jul; 88(3):276-281. PubMed ID: 28434899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diversity of β-lactamases produced by imipenem resistant, Pseudomonas aeruginosa isolates from the bloodstream.
    Najar Peerayeh S; Pirhajati Mahabadi R; Pakbaten Toupkanlou S; Siadat SD
    Burns; 2014 Nov; 40(7):1360-4. PubMed ID: 24513132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Phenotypic and genotypic characterization of imipenem-resistant Pseudomonas aeruginosa isolated in a Buenos Aires hospital].
    Cejas D; Almuzara M; Santella G; Tuduri A; Palombarani S; Figueroa S; Gutkind G; Radice M
    Rev Argent Microbiol; 2008; 40(4):238-45. PubMed ID: 19213249
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Imipenem and meropenem induced resistance to beta-lactam antibiotics in Pseudomonas aeruginosa.
    Giacometti A; Siquini FM; Cirioni O; Petroni S; Scalise G
    Eur J Clin Microbiol Infect Dis; 1994 Apr; 13(4):315-8. PubMed ID: 8070438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of imipenem resistance mechanisms in Pseudomonas aeruginosa isolates from Turkey.
    Mac Aogáin M; Kulah C; Rijnsburger M; Celebi G; Savelkoul PH; O'Gara F; Mooij MJ
    Clin Microbiol Infect; 2012 Jul; 18(7):E262-5. PubMed ID: 22591202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Resistance to imipenem in Pseudomonas aeruginosa: clinical experience and biochemical mechanisms.
    Quinn JP; Studemeister AE; DiVincenzo CA; Lerner SA
    Rev Infect Dis; 1988; 10(4):892-8. PubMed ID: 3142013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: report from the SENTRY Antimicrobial Surveillance Program.
    Ribeiro J; Mendes RE; Domingos R; França E; Silbert S; Jones RN; Sader HS
    J Chemother; 2006 Oct; 18(5):461-7. PubMed ID: 17127220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predicting doripenem susceptibility based on meropenem and imipenem interpretation for Pseudomonas aeruginosa.
    Hagihara M; Kuti JL; Nicolau DP
    Diagn Microbiol Infect Dis; 2012 Mar; 72(3):258-62. PubMed ID: 22209563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The frequency of PER-1 type extended spectrum beta-lactamases in nosocomial isolates of Pseudomonas aeruginosa].
    Zarakolu P; Metan G; Gürkan Aydin N; Altun B; Hasçelik G; Akova M
    Mikrobiyol Bul; 2007 Jul; 41(3):363-7. PubMed ID: 17933246
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.